FDA Announces Pilot Program Featuring Real-Time Clinical Trial Monitoring

The program will cut the time it takes to bring a drug to market, officials said.

The U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

Federal regulators on April 28 unveiled a pilot program for clinical trials, which they said would reduce the time it takes to test drugs.

The Food and Drug Administration program will feature real-time clinical trials or FDA staffers monitoring trials in real-time.